HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
MONDAY, Sept. 28, 2015 (HealthDay News) -- For terminally ill patients, hypoactive and mixed subtypes of delirium are associated with shorter survival periods, according to a study published online Sept. 18 in Psychosomatic Medicine.
Seon-Young Kim, M.D., Ph.D., from Chonnam National University Medical School in Gwangju, South Korea, and colleagues conducted a prospective cohort study involving 322 terminally ill patients. The authors examined the differential associations between delirium and mortality in terminally ill patients, according to delirium subtype and age.
The researchers found that 30.4 percent of the patients were diagnosed as having delirium. The median number of survival days after admission was 17.0 and 28.0 days for patients with and without delirium, respectively (P = 0.002). Compared to patients without delirium, shorter survival was seen for patients with hypoactive (hazard ratio [HR]: 1.65; 95 percent confidence interval [CI], 1.05 to 2.59; P = 0.029) and mixed subtypes of delirium (HR: 2.30, 95 percent CI, 1.44 to 3.69; P = 0.001). Significant interactions were seen for hypoactive and mixed delirium subtypes with age: younger age correlated with shorter periods of survival in patients with hypoactive (HR, 0.95; 95 percent CI, 0.93 to 0.98; P < 0.001) and mixed subtypes of delirium (HR, 0.97; 95 percent CI, 0.93 to 1.00; P = 0.038).
"These findings support the clinical and academic value of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition specifiers that differentiate the diagnoses of delirium subtypes," the authors write.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022